DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 26, 2006--Merrion Biopharma today announced the appointment of Jonathan O’Connell as Chief Financial Officer (CFO). He most recently served as CFO of Spectel, was previously with Trinity Biotech and was involved at critical stages in the development of both companies. According to John Lynch, Managing Director of Merrion Biopharma Ltd., “We are very pleased that Jonathan O’Connell has joined our team as CFO. His skills and experience will be an immense asset to us as we continue to develop and grow into the future.”
